JOHNSON & JOHNSON is 378.1x more valuable than ANAPTYSBIO, INC by market capitalization ($573.98 B vs $1.52 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ANAB | JNJ |
|---|---|---|
| Market cap | $1.52 B | $573.98 B |
| US-listed rank | #2314 | #20 |
| Revenue (latest FY) | $234.60M | $94.19B |
| Net income (latest FY) | -$13.23M | $26.80B |
| Net margin | -5.6% | 28.5% |
| P/E (trailing FY) | - | 21.4 |
| SEC filings | 681 | 984 |
JOHNSON & JOHNSON is 378.1x more valuable than ANAPTYSBIO, INC by market capitalization ($573.98 B vs $1.52 B).
In their latest fiscal years, ANAPTYSBIO, INC reported $234.60M in revenue while JOHNSON & JOHNSON reported $94.19B.
Full pages: ANAPTYSBIO, INC and JOHNSON & JOHNSON, or browse the full rankings.